ALX Oncology Holdings Inc. (ALXO) vs Inogen, Inc. (INGN)

A side-by-side comparison of ALX Oncology Holdings Inc. and Inogen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALXO vs INGN

growth of $100 · dividends reinvested · last 6y
ALXO -96.0% (-41.4%/yr)INGN -83.9% (-26.2%/yr)INGN compounded faster over this window
0100200300400Start $100202120222023202420252026$4$16
ALXO INGN

ALXO vs INGN: by the numbers

  • •INGN is the larger company ($157M vs $155M market cap).
  • •Both run net losses; ALXO's is the smaller (0.00% vs -6.94% net margin).

Metrics side by side

Valuation

MetricALXOINGN
P/S ratioN/A0.44
P/B ratio1.140.90

Profitability

MetricALXOINGN
Gross margin0.00%48.89%
Operating margin0.00%-8.45%
Net margin0.00%-6.94%
ROE-59.40%-14.07%
ROIC-56.53%-13.94%

Growth (annualized)

MetricALXOINGN
Revenue CAGR (5Y)N/A1.02%
Total return CAGR (5Y)-56.07%-32.83%

Frequently asked

How have ALXO and INGN total returns compared?
Over the past 5 years, ALXO delivered -56.07% and INGN delivered -32.83% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.